Tumours of the Central Nervous System (CNS) are an important cause of mortality from cancer. Epidemiological data on neoplams affecting the CNS are scarce in Brazil, especially in the Amazon region. The study aims at describing the histopathological profile of CNS tumours cases at a high-complexity referral cancer center. This study has described a 17-year-series profile of CNS tumours, registered at a high-complexity referral cancer center in Pará state, from January 1997 until July 2014 in the Brazilian Amazon Region. Data was gathered from histopathology reports kept in the hospital’s cancer registry and 949 cases of CNS tumours were analyzed. The most common histopathology were neuroepithelial tumours (approx. 40%) and meningioma was the most frequent especific tumor histologic subtype (22.2%). Neuroepithelial tumours were more frequent in patients with ages ranging from less than a year to 19 years, whereas metastatic tumours were prevalent in patients over 40 years of age. It was not found temporal trends during the studied period. The knowledge of these tumours profile is valuable for the understanding of cancer epidemiology in the region, since its prevalence is currently underreported and more awareness on the disease is needed.
Metastatic breast cancer (MBC) entails an overall 5-year survival of approximately 25%. The choice of therapy is influenced by expression of the HER2 gene and hormone receptors, by a disease-free interval, and by age. The use of paclitaxel combined with gemcitabine (doublet protocol) has shown efficacy as first-line treatment for MBC in either initial or maintenance therapy when compared to monotherapy with paclitaxel. There is evidence showing that the doublet protocol is a good alternative to maintenance therapy in women under 50 years old. Nevertheless, there is a lack of information concerning individuals above that age. We report the case of an 81-year-old patient presenting with recurrence of MBC, with lung and skin metastases both positive for hormone receptor and negative for HER2. We implemented a therapy based on the combination of gemcitabine and paclitaxel for 12 cycles, when complete response was achieved. Currently, 16 months after this achievement, the patient is receiving maintenance treatment under the doublet protocol, presenting acceptable parameters of toxicity since the beginning of treatment, which shows satisfactory tolerability and management of chemotherapy in an elderly patient. We suggest that the maintenance treatment protocol with a doublet might be an alternative with a satisfactory response in patients with MBC.
O câncer se caracteriza pelo crescimento desordenado de células, que podem invadir tecidos adjacentes ou órgãos à distância. O tratamento dessa patologia possui diversas reações adversas, dentre elas o ganho de peso. Em vista disso, a cinesioterapia se torna de extrema importância para mulheres com esse diagnóstico, por ser uma abordagem fisioterapêutica que consiste no uso do movimento como terapêutica, sendo uma ferramenta indispensável para restabelecer a função de membros e movimentos. Analisar se há associação da conduta nutricional e a cinesioterapia no manejo de peso. Trata-se de uma revisão integrativa da literatura, com busca realizada no mês de maio a junho de 2022. Para seleção dos artigos, realizaram-se buscas nas principais bases de dados BVS (Virtual Health Library) e PubMed (National Library of Medicine), este com busca de livre acesso à base de dados MEDLINE. Observou-se que muitas mulheres com câncer de mama desconhecem os efeitos colaterais do tratamento e não são orientadas a procurar a fisioterapia, o que retarda sua reabilitação. Entretanto, estudos comprovam que o acompanhamento e desenvolvimento de treinos com exercícios elaborados pelo fisioterapeuta contribui na melhora da força muscular, para realização de tarefas diárias como também da autoestima e confiança, melhorando com isso a qualidade de vida e auxiliando no manejo do peso e do estado nutricional. É notável a importância da atividade física contribuindo na melhora da qualidade de vida das pacientes que apresentam neoplasia de mama, diminuindo seu risco e melhorando o prognóstico.
Female breast cancer (FBC) is a well-known public health issue worldwide. However, male breast cancer (MBC), though rare, may be overlooked by both public health authorities and clinicians. Both diseases exhibit similarities, and understanding their behavior over time is crucial to grasping their annual impact on many citizens. Furthermore, analyzing if medical personnel are well allocated and influence disease outcomes in a limited setting such as the Public Health System (PHS) is of utmost importance. This ecological study utilized secondary data from 2008 to 2020 to explore the relationship between the number of doctors per 100,000 inhabitants and mortality from FBC and MBC in Brazil. All data were sourced from Brazil’s PHS. Mortality rates were analyzed by age and standardized according to the World Health Organization’s population figures. The number of physicians was calculated per 100,000 inhabitants. A linear regression analysis was performed using a stepwise selection/backward elimination approach. Between 2008 and 2020, Brazil recorded 195,969 breast cancer-related deaths among adults, including 2,220 male victims. The majority of these deaths occurred in the Southeast region among patients older than 50 years. Although both MBC and FBC demonstrated increasing trends over the study period, no correlation was found between the number of physicians and mortality rates for MBC. Conversely, an increase in primary care physicians over the years was positively correlated with mortality rates for FBC (p < 0.05). In addition, the number of physicians in the PHS (β = -0.163; 95% CI: -0.240 to -0.085; p = 0.002), oncologists (β = -0.507; 95% CI: -0.881 to -0.134; p = 0.015), and radiotherapists (β = -6.402; 95% CI: -12.357 to -0.446; p = 0.039) all showed an inverse association with FBC mortality. The increasing trends in FBC and MBC underscore the need for urgent monitoring. Lower FBC mortality correlates with higher numbers of physicians and specialized care, highlighting the critical role of healthcare workforce capacity and the strategic allocation of specialized personnel in enhancing patient outcomes.
1 January 2015 in International Archives of Medicine
Metastatic Colorectal Cancer Treated with FOLFOX + Cetuximab in Long Term Use Protocol. Complete Responses and Acceptable Tolerability Profie. Case Series
To determine how lung cancer mortality differ by region in Brazil and whether these differences correlate with patient sex, income inequality and number of physicians involved in lung cancer treatment. Female sex, year of death and higher number of broncoesophalogists were all associated with lower mortality (p < 0.05), whereas a higher number of family medicine doctors, thoracic surgeons, pneumologists and a higher average income were associated with higher mortality rates (p < 0.05).